Clinical Trial

MA-CRC-II-016 SHR-1811

Name: MA-CRC-II-016 SHR-1811 — clinical trial record (NCT07355764)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A randomized, controlled, multicenter clinical study of SHR-A1811 combined with bevacizumab for the second-line treatment of metastatic colorectal cancer

Trial Details

NCT Number	NCT07355764
Lead Sponsor	Peking Union Medical College Hospital
Conditions	mCRC, HER2, Targeted Therapy, Antibody-drug Conjugates
Enrollment	80 participants
Start Date	2025-12-30
Primary Completion	2028-01-30 (estimated)
Study Completion	2028-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-21